期刊文献+

血糖波动对重症监护病房危重症患者预后的影响 被引量:29

The effect of blood glucose fluctuations on prognosis of critically ill patients in intensive care unit
原文传递
导出
摘要 目的探讨血糖波动对重症监护病房(ICU)危重症患者预后的影响。方法回顾性分析90例ICU危重症患者的临床资料,监测入住ICU72h内血糖值,记录初始血糖(GluAdm)、平均血糖(GluAve)、血糖标准差(GluSD)、血糖变异系数(GluCV)。按患者预后分为存活组(49例)与死亡组(41例),比较两组间GluAdm、GluAve、GluSD、GluCV的差异,应用受试者工作特征曲线(ROC曲线)评价血糖波动与预后的相关性。根据GluSD、GluCV值平均分为4个亚组,比较各亚组间ICU病死率及院内病死率。结果死亡组患者G1uAdm、GluAve、GluSD、GluCV均明显高于存活组[GluAdm:(11.47±3.91)mmol/L比(9.23±2.96)mmol/L,GluAve:(9.22±1.31)mmol/L比(8.Z8±1.15)mmol/L,GluSD:(2.62±0.97)mmol/L比(1.66±0.64)mmol/L,GluCV:0.28±0.10比0.20±0.07,P均〈0.053;GluSD、GluCV的ROC曲线下面积(AUC)分别为0.782±0.049和0.757±0.053,明显高于GluAdm、GluAve的AuC(分别为0.669±0.058和0.690±0.056,P均〈0.05)。GluSD4.35~5.66mmol/L组ICU病死率为95.7%,院内病死率为98.6%;GluCV0.378-0.500组ICU病死率为83.3%,院内病死率为100.0%。结论GluSD、GluCV升高与危重症患者ICU病死率和院内病死率显著相关,较GluAdm、GluAve评价预后更准确;降低血糖波动是有效控制血糖的重要策略。 Objective To determine the assoeiation between glucose fluetuations and hospital mortality in intensive care unit (ICU) patients. Methods A retrospeetive study involving 90 eritically ill patients in ICU according to the patients' outcome were divided into survivors (49 cases) and nonsurvivors (41 cases), in whom the blood glucose level was monitored in the first 72 hours, and the initial blood glucose (GluAdm), the average blood glucose (GluAve), glucose standard deviation (GIuSD), coefficient of variation glucose (GluCV) were determined, then GluAdm, GluAve, GluSD, and GluCV were compared between survivors and nonsurvivors, and the receiver operating characteristic curve (ROC eurve) was applied to evaluate the assoeiation between blood glueose fluetuation and prognosis. According to the values of GluSD, GluCV, the critically patients were divided into four subgroups, and mortality in ICU and hospital was compared. Results The levels of GluAdm, GluAve, GluSD, GluCV of nonsurvivors were higher than those of survivors fGluAdm: (11.47 ± 3. 91) mmol/L vs. (9. 23 ± 2. 96) retool/L, GluAve: (9.22 ± 1.31) mmol/L vs. (8.28± 1.15) retool/L, GluSD: (2.62 ±0.97) mmol/L vs. (1.66±0.64) mmol/L, GluCV: 0.28± 0.10 vs. 0. 20±0. 07, all P〈0. 053. When ROC was applied, the area under the curve (AUC) of GluSD, GluCV were 0. 782±0. 049 and 0. 757±0. 053, they were higher than that of the GluAdm and GluAve (0. 669±0. 058 and 0. 690±0. 056, both P〈0. 05). When GluSD was 4.35 -5.66 mmol/L, the ICU mortality was 95.7%, hospital mortality was 98.6%; when GluCV was 0. 378 -0.500, the ICU mortality was 83.3%, hospital mortality was 100. 0%. Conclusion The increase in GluSD and GluCV in critically ill patients is significantly correlated with ICU mortality and hospital mortality, and they are more valuable in predicting ICU mortality than GluAdm, GluAve. Diminution in fluctuation of blood glucose might be an important aspect of glucose management.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2009年第8期466-469,共4页 Chinese Critical Care Medicine
关键词 危重症 血糖波动 预后 强化胰岛素治疗 critical illness blood glucose variability prognosis intensive insulin therapy
  • 相关文献

参考文献15

  • 1Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med, 2001,345 (19) :1359-1367.
  • 2Devos P, Preiser J, Melot C, et al. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia:final results of the Glu control study. Intensive Care Med,2007,33(Suppl 2):S189.
  • 3Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med, 2008, 36 (1) 296-327.
  • 4Brunkhorst FM, Kuhnt E, Engel C, et al. Intensive insulin therapy in patient with severe sepsis and septic shock is associated with an increased rate of hypoglycemia:results from a randomized multicenter study (VISEP). Infection, 2005, 33 (Suppl 1) :19.
  • 5Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med, 2008,358 (2) : 125-139.
  • 6Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med, 2006,354 (5) ..449-461.
  • 7王灵聪,雷澍,吴艳春,吴建浓,王兰芳,关天容,蒋慧芳,倪海祥,叶雪惠.危重病患者抢救中胰岛素强化治疗的探讨[J].中国危重病急救医学,2006,18(12):748-750. 被引量:35
  • 8江学成,胡宁利.中文版《危重疾病评分系统》计算机软件[J].中国危重病急救医学,2000,12(4):246-247. 被引量:85
  • 9叶任高,陆再英.内科学.6版.北京:人民卫生出版社,2005:815-820.
  • 10Swets JA. Measuring the accuracy of diagnostic systems. Science, 1988,240 (4857) : 1285-1293.

二级参考文献14

  • 1McCowen K C,Malhotra A,Bistrian B R.Stress-induced hyperglycemia[J].Crit Care Clin,2001,17:107-124.
  • 2Scott J F,Robinson G M,French J M,et al.Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia:the glucose insulin in stroke trial (GIST)[J].Stroke,1999,30:793-799.
  • 3Fietsam R Jr,Bassett J,Glover J L.Complications of coronary artery surgery in diabetic patients[J].Am Surg,1991,57:551-557.
  • 4Cerra F B.Hypermetabolism,organ failure,and metabolic support[J].Surgery,1987,101:1-14.
  • 5Wolfe R R,Herndon D N,Jahoor F,et al.Effect of severe burn injury on substrate cycling by glucose and fatty acids[J].N Engl J Med,1987,317:403-408.
  • 6Shangraw R E,Jahoor F,Miyoshi H,et al.Differentiation between septic and postburn insulin resistance[J].Metabolism,1989,38:983-989.
  • 7Weise K,Zaritsky A.Endocrine manifestations of critical illness in the child[J].Pediatr Clin North Am,1987,34:119-130.
  • 8Malmberg K.Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus[J].BMJ,1997,314:1512-1515.
  • 9van den Berghe G,Wouters P,Weekers F,et al.Intensive insulin therapy in the critically ill patients[J].N Engl J Med,2001,345:1359-1367.
  • 10Takala J,Ruokonen E,Webster N R,et al.Increased mortality associated with growth hormone treatment in critically ill adults[J].N Engl J Med,1999,341:785-792.

共引文献116

同被引文献271

引证文献29

二级引证文献272

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部